Review Article
Recent Advances in Developing Insect Natural Products as Potential Modern Day Medicines
Table 5
Summary of factors/processes involved in maggot therapy of infected wounds.
| Factors/processes mediated by maggot extracts and secretions | Effect on wound | References |
| Debridement | | | (1) Maggot proteases | Digest wound debris | Chambers et al. [132] | (2) Maggot DNase | Digest DNA of debris and infecting bacteria in biofilms | Brown et al. [133] | (3) Maggot glycosidases | Digest wound debris | Telford et al. [134] | Wound healing | | | (4) Specific amino acids | Induce mitosis in endothelial cells | Bexfield et al. [135] | (5) Maggot fatty acid extracts | Activate angiogenesis | Zhang et al. [136] | (6) Neutrophil migration inhibition | Resolves inflammation |
van der Plas et al. [137] | (7) Macrophage migration inhibition and TNF-α. | Resolves inflammation helped by increased IL-10 |
van der Plas et al. [138] | (8) Anti-inflammatory macrophages increased | Resolves inflammation helped by bFGF and VEGF cytokines inducing mitosis and angiogenesis |
van der Plas et al. [139] | (9) Lymphocyte activation suppressed | Inhibits adaptive immunity to maggot proteins | Elkington et al. [140] | (10) Reduced complement activation | Inhibits complement action against maggot proteins | Cazander et al. [141] | Wound disinfection | | | (11) Maggot lucifensin | Active against gram-positive bacteria, for example, MRSA |
Čeřovský et al. [142] Andersen et al. [143] | (12) Maggot alloferons | Antiviral and antitumour activities | Chernysh et al. [144] | (13) Maggot seraticin | Active against gram-positive and gram-negative bacteria | Bexfield et al. [145] |
|
|